Beta Drugs (NSE:BETA) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


NSE:BETA Beta Drugs Ltd NSE:BETA
82 GF Score
Price ₹2,096.60
GF Value ₹1,960.95
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Beta Drugs Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-26), Beta Drugs's Predictability Rank is 4.5-Stars. Beta Drugs's intrinsic value calculated from the Discounted FCF model is ₹413.11 and current share price is ₹2096.60. Consequently,

Beta Drugs's Margin of Safety % (DCF FCF Based) using Discounted FCF model is N/A.

NSE:BETA vs ZTS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Margin of Safety % (DCF FCF Based) falls into.


NSE:BETA
82GF Score
Beta Drugs Ltd NSE:BETA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Drugs Margin of Safety % (DCF FCF Based) Calculation

Beta Drugs's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(-148.34-2096.60)/-148.34
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Is Beta Drugs (NSE:BETA) Overvalued in 2026?

Based on GuruFocus' analysis, Beta Drugs stock appears to be overvalued. The current stock price of ₹2,096.60 is trading 6.9% above its estimated GF Value™ of ₹1,960.95. GuruFocus considers Beta Drugs to be Fairly Valued.

Key valuation signals for NSE:BETA:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₹1,960.95 vs. price of ₹2,096.60 (6.9% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the NSE:BETA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beta Drugs Business Description

Address SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries, of which key revenue is derived from the sales made in India.
82GF Score

Get the complete analysis for NSE:BETA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,096.60
Price
₹1,960.95
GF Value